Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Marketing Clinical Study to Evaluate the Safety of Elunate® (Fruquintinib Capsules) in Chinese Patients.

NCT04005066 is registered in ClinicalTrials.gov with Hutchmed as lead sponsor.

NCT NCT04005066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04005066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Marketing Clinical Study to Evaluate the Safety of Elunate® (Fruquintinib Capsules) in Chinese Patients.
Lead sponsor
Hutchmed
Phase
Observational
Overall status
Completed
Start date
April 20, 2019
Completion date
September 27, 2022
Enrollment
3,005 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patient safety